CDKN2A and intrahepatic cholangiocarcinoma: A subsequent meta-analysis of 4,458 patients with the study of 102 individual markers revealed that genetic alterations of HER2 and TP53 were more common in ECC, and BCL-2, EGFR, SMAD4, p16 and VEGF-A were more frequent in ICC [33].